Silgan: After Disregarding High Mold and Yeast Results in Manufactured Products, FDA Says Company Should Overhaul Quality System; Expert Says Findings Place Companies at Risk of FDA Withholding Approvals for Product Applications

Silgan Dispensing Systems (SLGN), a contract manufacturer of consumer health care products, didn’t properly investigate or report high mold and yeast counts for drug products made in its Spokane, Washington manufacturing facility, even after an unnamed customer issued a recall due to potential fungal contamination of a product made by Silgan, according to a recent […]

Published on Oct 20, 2026

Already have an account? Log in.

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.

View Only Unlocked Articles

Copyright ©2026 The Capitol Forum. All Rights Reserved.